Latest Market Share News

Cogstate Limited reports a record-breaking quarter with sales contracts soaring 88% year-on-year, driven by expanding markets and new therapeutic areas. The company signals continued investment in growth initiatives, including AI and Asia-Pacific expansion, while projecting a strong first half of FY26.

MyEco Group reported a modest 2% rise in Q1 FY26 sales, driven by a doubling in council and waste channel revenues despite ongoing headwinds from U.S. tariff changes impacting white label sales.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

Mount Gibson Iron Limited has agreed to acquire a 50% interest in the Central Tanami Gold Project, marking a strategic shift towards gold production while maintaining steady iron ore operations at Koolan Island.

Orora Limited has finalized its strategic portfolio transformation, delivering solid FY25 financial results despite softness in its glass segment. The company outlines a cautiously optimistic FY26 outlook, underpinned by sustainability progress and investments in beverage packaging innovation.

Articore Group Limited has reported its first profitable quarter in four years, delivering a $0.8 million EBIT in 1QFY26 and reaffirming its FY26 guidance amid strategic investments in AI and new product launches.

Bank of Queensland reported a robust FY25 with 12% growth in cash earnings and significant progress in its digital banking and branch conversion initiatives. The bank’s focus on productivity and specialist business lending underpins its optimistic outlook despite ongoing economic uncertainties.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

Aussie Broadband reported robust FY25 results with nearly $1.2 billion revenue and signed a transformative six-year wholesale agreement, setting the stage for ambitious growth through FY28.

Clarity Pharmaceuticals’ Co-PSMA Phase II trial shows its Cu-SAR-bisPSMA diagnostic agent detects more prostate cancer lesions than current standard imaging, promising earlier and more accurate recurrence detection.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Treasury Wine Estates has withdrawn its fiscal 2026 EBIT growth guidance following softer-than-expected Penfolds sales in China and distribution disruptions in California, signaling a cautious outlook for its key markets.